Kentucky Revised Statutes · § 218A.513 — Ibogaine research and intellectual property fund

(1) There is hereby established in the State Treasury a trust and agency fund entitled the ibogaine research and intellectual property fund, to be administered by the department for the purpose of allowing the department to enter into a public-private partnership with a drug developer to conduct a clinical drug development trial or trials related to the use of ibogaine for the treatment of opioid use disorder, co-occurring substance use disorder, or any other neurological or mental health condition for which ibogaine demonstrates efficacy.

(2) The fund may receive state appropriations, gifts, grants, federal funds, and any other funds, both public and private. Moneys deposited in the fund are to be used for the purposes set out in KRS 218A.511 to 218A.519.

(3) Notwithstanding KRS 45.229, any unallocated or unencumbered balances in the fund shall be invested as provided in KRS 42.500(9), and any interest or other income earned from the investments, along with the unallotted or unencumbered balances in the fund, shall not lapse but shall be carried forward into the next fiscal year.